<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08055267241514</udiDi>
    <basicUdiDi>80336618004210100000000QS</basicUdiDi>
    <tradeName>TRIUM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001260</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.346Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241521</udiDi>
    <basicUdiDi>80336618004210100000000QS</basicUdiDi>
    <tradeName>TRIUM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001261</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.331Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241538</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>EDENORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001249</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.322Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241583</udiDi>
    <basicUdiDi>80336618004030100000000QE</basicUdiDi>
    <tradeName>HYALFID</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001265</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.290Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241590</udiDi>
    <basicUdiDi>80336618004030100000000QE</basicUdiDi>
    <tradeName>HYALFID</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001266</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.279Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241606</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>EDENORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001255</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.265Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241613</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001253</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.224Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241620</udiDi>
    <basicUdiDi>80336618004210100000000QS</basicUdiDi>
    <tradeName>TRIUM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001262</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.214Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241637</udiDi>
    <basicUdiDi>80336618004210200000000RH</basicUdiDi>
    <tradeName>TRIUM MONODOSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001267</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.202Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241651</udiDi>
    <basicUdiDi>80336618004030100000000QE</basicUdiDi>
    <tradeName>BLUYAL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001263</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.190Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267242894</udiDi>
    <basicUdiDi>80336618006030100000000SY</basicUdiDi>
    <tradeName>HIDRAFEM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0899</emdnCode>
    <emdnDescription>GYNAECOLOGICAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001814</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.156Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-195800QJ</udiDi>
    <basicUdiDi>B-195800QJ</basicUdiDi>
    <tradeName>BIONECT START</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>195800</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:46:04.038Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-206213ME</udiDi>
    <basicUdiDi>B-206213ME</basicUdiDi>
    <tradeName>FIDIAL PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>206213</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:46:02.318Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AQ1407_1BLR</udiDi>
    <basicUdiDi>B-AQ1407_1BLR</basicUdiDi>
    <tradeName>RYM QUEMADURAS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>114325</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:32:57.090Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SOOFT101YW</udiDi>
    <basicUdiDi>B-SOOFT101YW</basicUdiDi>
    <tradeName>I-ON CXL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>IONTOPHORESIS EQUIPMENT</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SOOFT101</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:55:12.006Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SOOFT164ZN</udiDi>
    <basicUdiDi>B-SOOFT164ZN</basicUdiDi>
    <tradeName>FLUOROFTA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SOOFT164</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:55:11.992Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241446</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-27T04:35:20.825Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241460</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-27T04:35:20.797Z</lastUpdated>
  </row>
</eudamedExport>